Login Get Started
Browse
Shares
Healthcare
Biotechnology & Medical Research
Telesta Therapeutics Inc
Telesta Therapeutics Inc logo

TST - Telesta Therapeutics Inc Share News

C$0.13 0.0  0.0%

Last Trade - 01/11/16

Sector
Healthcare
RiskRating
Size
Micro Cap
Style
Market Cap £n/a
Enterprise Value £n/a
Revenue £7.44m
Position in Universe th / 2684
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions TST Dividends
All News
All News Reuters News Company Announcements
BRIEF-Telesta Therapeutics announces final court approval of plan of arrangement with Prometic Life Sciences
28th Oct '16 News
BRIEF-Telesta Therapeutics shareholders approve plan of arrangement with Prometic Life Sciences
25th Oct '16 News
BRIEF-Telesta says ISS, Glass Lewis recommend shareholders vote for plan of arrangement between co, Prometic Life Sciences
11th Oct '16 News
BRIEF-K2 Principal Fund says acquired additional 6.6 mln shares in Telesta Thereapeutics
10th Oct '16 News
BRIEF-K2 Principal Fund says after acquisition K2 owns 18 mln shares of Telesta
29th Aug '16 News
BRIEF-Prometic Life Sciences to acquire Telesta Therapeutics
24th Aug '16 News
BRIEF-Telesta Therapeutics provides strategic update
2nd Aug '16 News
BRIEF-Telesta Therapeutics posts Q3 net loss of $1.6 mln vs $3.3 mln in 2015
10th May '16 News
BRIEF-Telesta currently estimates that U.S.approval for MCNA can not be obtained for a period of at least 5 years
18th Apr '16 News
BRIEF-Telesta Therapeutics says type A meeting has been scheduled with U.S. FDA
12th Apr '16 News
BRIEF-Telesta Therapeutics provides corporate update
9th Mar '16 News
BRIEF-Telesta Therapeutics provides an update on biologics license application for drug MCNA1
14th Dec '15 News
BRIEF-Telesta Therapeutics announces results of FDA advisory committee vote
19th Nov '15 News
BRIEF-Telesta Therapeutics announces results of FDA advisory committee vote
19th Nov '15 News
BRIEF-Telesta Therapeutics posts Q1 loss of $3.9 mln
12th Nov '15 News
BRIEF-Press release - Telesta Therapeutics and Ipsen announce exclusive license agreement for MCNA(1) for the treatment of non-muscle invasive bladder cancer in major ex-United States territories
28th Oct '15 News
BRIEF-Ipsen and Telesta Therapeutics announce exclusive license agreement for MCNA1
28th Oct '15 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.